×
Bayer Revenue 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Bayer revenue for the twelve months ending December 31, 2024 was
$50.432B
, a
2.18% decline
year-over-year.
Bayer annual revenue for 2024 was
$50.432B
, a
2.18% decline
from 2023.
Bayer annual revenue for 2023 was
$51.558B
, a
3.56% decline
from 2022.
Bayer annual revenue for 2022 was
$53.459B
, a
2.5% increase
from 2021.
View More
Bayer Revenue 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Bayer annual revenue for 2024 was
$50.432B
, a
2.18% decline
from 2023.
Bayer annual revenue for 2023 was
$51.558B
, a
3.56% decline
from 2022.
Bayer annual revenue for 2022 was
$53.459B
, a
2.5% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$796.4B
Johnson & Johnson (JNJ)
$379.5B
AbbVie (ABBV)
$306B
Novo Nordisk (NVO)
$260.6B
Roche Holding AG (RHHBY)
$248.1B
Novartis AG (NVS)
$234.2B
Merck (MRK)
$196.7B
Sanofi (SNY)
$128.6B
Pfizer (PFE)
$125.6B
Innoviva (INVA)
$1.1B